BibTex RIS Kaynak Göster
Yıl 2015, Cilt: 2 Sayı: 2, 135 - 157, 29.06.2015

Öz

ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY

Yıl 2015, Cilt: 2 Sayı: 2, 135 - 157, 29.06.2015

Öz

The numbers of Chronic Kidney Failure (CKF) cases have increased dramatically in last years in Turkey. For that reason, the causes of CKFs and costs related to treatment of CKF are being assessed to compare the types of treatments and to plan the necessary budget. Through this study, the aim is to view the success factors of CKF treatment and quantify the results by Decision Tools. Hypertension and Diabetics are main causes of CKF. In a past study carried out by (Aslan&Ozen, 2013) in Turkey, it was found that first three stages of CKF are generally ignored and attention is given to the last two stages of CKF kidneys not being able to perform their functions.  In the first case study, the average cost for treatment for each patient and probabilities are drawn to estimate future costs. In the second case study, average lifespan, average parameters of important body signs and cost estimations under different conditions were presented based on the data of Turkish Society Nephrology (TNS). The most beneficial treatment method is Transplantation (TX), but it is not possible to find a donor for each patient. The expected lifespan is higher for Haemodialysis (HD)  patients but, Dialysis(PD) provides more flexibility than HD. The expected cost of a patient for his/her living years with HD is 160,933.04 TL/Life and the expected cost of a PD patient during the life span is 142, 730.67 TL/life.

Toplam 0 adet kaynakça vardır.

Ayrıntılar

Bölüm Articles
Yazarlar

İmran Aslan

Yayımlanma Tarihi 29 Haziran 2015
Yayımlandığı Sayı Yıl 2015 Cilt: 2 Sayı: 2

Kaynak Göster

APA Aslan, İ. (2015). ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY. Research Journal of Business and Management, 2(2), 135-157. https://doi.org/10.17261/Pressacademia.2015211503
AMA Aslan İ. ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY. RJBM. Kasım 2015;2(2):135-157. doi:10.17261/Pressacademia.2015211503
Chicago Aslan, İmran. “ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY”. Research Journal of Business and Management 2, sy. 2 (Kasım 2015): 135-57. https://doi.org/10.17261/Pressacademia.2015211503.
EndNote Aslan İ (01 Kasım 2015) ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY. Research Journal of Business and Management 2 2 135–157.
IEEE İ. Aslan, “ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY”, RJBM, c. 2, sy. 2, ss. 135–157, 2015, doi: 10.17261/Pressacademia.2015211503.
ISNAD Aslan, İmran. “ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY”. Research Journal of Business and Management 2/2 (Kasım 2015), 135-157. https://doi.org/10.17261/Pressacademia.2015211503.
JAMA Aslan İ. ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY. RJBM. 2015;2:135–157.
MLA Aslan, İmran. “ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY”. Research Journal of Business and Management, c. 2, sy. 2, 2015, ss. 135-57, doi:10.17261/Pressacademia.2015211503.
Vancouver Aslan İ. ESTIMATING AVERAGE LIFESPAN AND EXPECTED COSTS FOR CHRONIC KIDNEY FAILURE (CKF) IN TURKEY. RJBM. 2015;2(2):135-57.

Research Journal of Business and Management (RJBM) is a scientific, academic, double blind peer-reviewed, quarterly and open-access online journal. The journal publishes four issues a year. The issuing months are March, June, September and December. The publication languages of the Journal are English and Turkish. RJBM aims to provide a research source for all practitioners, policy makers, professionals and researchers working in all related areas of business, management and organizations. The editor in chief of RJBM invites all manuscripts that cover theoretical and/or applied researches on topics related to the interest areas of the Journal. RJBM publishes academic research studies only. RJBM charges no submission or publication fee.

Ethics Policy - RJBM applies the standards of Committee on Publication Ethics (COPE). RJBM is committed to the academic community ensuring ethics and quality of manuscripts in publications. Plagiarism is strictly forbidden and the manuscripts found to be plagiarized will not be accepted or if published will be removed from the publication. Authors must certify that their manuscripts are their original work. Plagiarism, duplicate, data fabrication and redundant publications are forbidden. The manuscripts are subject to plagiarism check by iThenticate or similar. All manuscript submissions must provide a similarity report (up to 15% excluding quotes, bibliography, abstract, method).

Open Access - All research articles published in PressAcademia Journals are fully open access; immediately freely available to read, download and share. Articles are published under the terms of a Creative Commons license which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Open access is a property of individual works, not necessarily journals or publishers. Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.